ECMO showdown: which strategy saves more lives in High-Risk heart procedures?
NCT ID NCT06274411
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at two different ways to use a heart-lung machine (ECMO) during high-risk heart procedures. One method sets up the machine just in case it's needed, while the other uses it from the start. The goal is to see which approach leads to fewer serious problems like death, heart attack, or stroke. About 176 adults with weak hearts or complex blockages will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ECMO are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Anzhen Hospital
RECRUITINGBeijing, Beijing Municipality, 100029, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New blood thinning combo could cut ECMO bleeding and clotting risks
- New heart pump could replace ECMO in risky angioplasty
- Can a pupil check predict brain recovery? new study tests Super-Early clues in ECMO patients
- New study to track survival in High-Risk heart procedures
- Can a heart pump make risky stent placements safer?
- Lung machine may also impact kidneys, study suggests